These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 17204308

  • 1. Statin therapy does not seem to benefit giant cell arteritis.
    Narváez J, Bernad B, Nolla JM, Valverde J.
    Semin Arthritis Rheum; 2007 Apr; 36(5):322-7. PubMed ID: 17204308
    [Abstract] [Full Text] [Related]

  • 2. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.
    Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M.
    Arthritis Rheum; 2004 Apr; 50(4):1332-7. PubMed ID: 15077317
    [Abstract] [Full Text] [Related]

  • 3. Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis.
    Narváez J, Bernad B, Gómez-Vaquero C, García-Gómez C, Roig-Vilaseca D, Juanola X, Rodriguez-Moreno J, Nolla JM, Valverde J.
    Clin Exp Rheumatol; 2008 Apr; 26(3 Suppl 49):S57-62. PubMed ID: 18799055
    [Abstract] [Full Text] [Related]

  • 4. Treatment with statins does not exhibit a clinically relevant corticosteroid-sparing effect in patients with giant cell arteritis.
    García-Martínez A, Hernández-Rodríguez J, Grau JM, Cid MC.
    Arthritis Rheum; 2004 Aug 15; 51(4):674-8. PubMed ID: 15334444
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M, Hunder GG, Easley KA, Calamia KT, Matteson EL, Griffing WL, Younge BR, Weyand CM, Goronzy JJ.
    Arthritis Rheum; 2006 Oct 15; 54(10):3310-8. PubMed ID: 17009270
    [Abstract] [Full Text] [Related]

  • 6. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.
    Mahr AD, Jover JA, Spiera RF, Hernández-García C, Fernández-Gutiérrez B, Lavalley MP, Merkel PA.
    Arthritis Rheum; 2007 Aug 15; 56(8):2789-97. PubMed ID: 17665429
    [Abstract] [Full Text] [Related]

  • 7. Is statin exposure associated with occurrence or better outcome in giant cell arteritis? Results from a French population-based study.
    Pugnet G, Sailler L, Bourrel R, Montastruc JL, Lapeyre-Mestre M.
    J Rheumatol; 2015 Feb 15; 42(2):316-22. PubMed ID: 25512477
    [Abstract] [Full Text] [Related]

  • 8. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.
    Lopez-Diaz MJ, Llorca J, Gonzalez-Juanatey C, Peña-Sagredo JL, Martin J, Gonzalez-Gay MA.
    Semin Arthritis Rheum; 2008 Oct 15; 38(2):116-23. PubMed ID: 18221984
    [Abstract] [Full Text] [Related]

  • 9. Giant cell arteritis: diagnosing and treating inflammatory disease in older adults.
    Azhar SS, Tang RA, Dorotheo EU.
    Geriatrics; 2005 Aug 15; 60(8):26-30. PubMed ID: 16092890
    [Abstract] [Full Text] [Related]

  • 10. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment.
    González-Gay MA, Blanco R, Rodríguez-Valverde V, Martínez-Taboada VM, Delgado-Rodriguez M, Figueroa M, Uriarte E.
    Arthritis Rheum; 1998 Aug 15; 41(8):1497-504. PubMed ID: 9704651
    [Abstract] [Full Text] [Related]

  • 11. Statin or nonsteroidal anti-inflammatory drug use is associated with lower erythrocyte sedimentation rate in patients with giant cell arteritis.
    Hegg R, Lee AG, Tagg NT, Zimmerman MB.
    J Neuroophthalmol; 2011 Jun 15; 31(2):135-8. PubMed ID: 21358421
    [Abstract] [Full Text] [Related]

  • 12. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients.
    Chevalet P, Barrier JH, Pottier P, Magadur-Joly G, Pottier MA, Hamidou M, Planchon B, El Kouri D, Connan L, Dupond JL, De Wazieres B, Dien G, Duhamel E, Grosbois B, Jego P, Le Strat A, Capdeville J, Letellier P, Agron L.
    J Rheumatol; 2000 Jun 15; 27(6):1484-91. PubMed ID: 10852275
    [Abstract] [Full Text] [Related]

  • 13. Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis.
    Narváez J, Bernad B, Roig-Vilaseca D, García-Gómez C, Gómez-Vaquero C, Juanola X, Rodriguez-Moreno J, Nolla JM, Valverde J.
    Semin Arthritis Rheum; 2007 Aug 15; 37(1):13-9. PubMed ID: 17360027
    [Abstract] [Full Text] [Related]

  • 14. Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population.
    Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, Llorca J.
    Arthritis Rheum; 2004 Aug 15; 51(4):652-5. PubMed ID: 15334440
    [Abstract] [Full Text] [Related]

  • 15. Duration of corticosteroid therapy in giant cell arteritis.
    Fernandez-Herlihy L.
    J Rheumatol; 1980 Aug 15; 7(3):361-4. PubMed ID: 6772784
    [Abstract] [Full Text] [Related]

  • 16. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.
    Martínez-Taboada VM, Rodríguez-Valverde V, Carreño L, López-Longo J, Figueroa M, Belzunegui J, Mola EM, Bonilla G.
    Ann Rheum Dis; 2008 May 15; 67(5):625-30. PubMed ID: 18086726
    [Abstract] [Full Text] [Related]

  • 17. High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.
    Berger CT, Wolbers M, Meyer P, Daikeler T, Hess C.
    Rheumatology (Oxford); 2009 Mar 15; 48(3):258-61. PubMed ID: 19129348
    [Abstract] [Full Text] [Related]

  • 18. [Polymyalgia rheumatica and temporal arteritis].
    Vos PA, Bijlsma JW, Derksen RH.
    Ned Tijdschr Geneeskd; 2005 Aug 27; 149(35):1932-7. PubMed ID: 16159030
    [Abstract] [Full Text] [Related]

  • 19. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I, Henes JC, Wagner AD, Loock J, Gross WL.
    Clin Exp Rheumatol; 2012 Aug 27; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [Abstract] [Full Text] [Related]

  • 20. Role of oral cyclophosphamide in the treatment of giant cell arteritis.
    Quartuccio L, Maset M, De Maglio G, Pontarini E, Fabris M, Mansutti E, Mariuzzi L, Pizzolitto S, Beltrami CA, De Vita S.
    Rheumatology (Oxford); 2012 Sep 27; 51(9):1677-86. PubMed ID: 22627726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.